by EPHA | Mar 23, 2017 | Reports, Statements
British and European patients are likely to pay a high price for Brexit, concluded Brexit, Trade and Health, an event organised by the European Public Health Alliance (EPHA) in partnership with the University of Manchester and the Economic and Social Research Council...
by EPHA | Mar 22, 2017 | Reports, Statements
The challenge of Hepatitis C in Central and South Eastern Europe was at the heart of an event hosted by the MEP Friends of the Liver Interest Group co-chairs Dr Cristian Busoi, MEP, Dr Biljana Borzan, MEP and Dr Andrey Kovatchev, MEP and co-organised by the European...
by EPHA | Mar 6, 2017 | Opinion, Statements
Disclaimer: this briefing is based on a public hearing of the European Parliament Internal Market and Consumer Protection (IMCO) Committee held on 28th February 2017 on ‘The consequences of Brexit” On 17th January 2017 the Prime Minister of the United Kingdom (UK) set...
by European Public Health Alliance | Mar 2, 2017 | News Release, Statements
Brussels, 2 March 2017. The European Public Health Alliance welcomes the report on access to medicines adopted by the European Parliament Plenary this morning. The Parliament’s own initiative report addresses the challenge posed to national healthcare budgets by high...
by EPHA | Feb 16, 2017 | Statements
Brussels, Monday 13th February- Mental health is everyone’s concern. It is central to all our lives and impacts our well-being, our work, our societies, our families and our economies. We, the undersigned European organisations, are concerned by the mental health of...
by EPHA | Feb 15, 2017 | Statements
Brussels, 15 February 2017. The European Parliament in the presence of Canadian Prime Minister Justin Trudeau rubber-stamped the Comprehensive Economic and Trade Agreement (CETA) between the EU and Canada. The deal, opposed by a coalition of civil society...
